Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9 EUR | 0.00% | -1.10% | -1.64% |
Apr. 11 | DocCheck AG Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | DocCheck AG Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
Valuation
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 35.68 | 45.91 | 117.7 | 155.5 | 73.24 | 46.43 |
Enterprise Value (EV) 1 | 25.28 | 37.46 | 98.51 | 134.9 | 58.5 | 29.8 |
P/E ratio | 15.9 x | 14.6 x | 12.9 x | 13.7 x | 11.7 x | 20.4 x |
Yield | 5.59% | 1.09% | 4.27% | 3.24% | 5.15% | 5.46% |
Capitalization / Revenue | 1.26 x | 1.42 x | 1.87 x | 1.81 x | 1.2 x | 0.87 x |
EV / Revenue | 0.89 x | 1.16 x | 1.56 x | 1.57 x | 0.96 x | 0.56 x |
EV / EBITDA | 6.29 x | 7.22 x | 6.88 x | 7.57 x | 5.62 x | 4.06 x |
EV / FCF | 20.5 x | 94 x | 12.8 x | 22.2 x | -31.6 x | 4.61 x |
FCF Yield | 4.89% | 1.06% | 7.79% | 4.5% | -3.17% | 21.7% |
Price to Book | 1.71 x | 2.08 x | 3.8 x | 4.17 x | 1.9 x | 1.24 x |
Nbr of stocks (in thousands) | 4,990 | 4,990 | 5,030 | 5,034 | 5,034 | 5,074 |
Reference price 2 | 7.150 | 9.200 | 23.40 | 30.90 | 14.55 | 9.150 |
Announcement Date | 4/9/19 | 4/21/20 | 4/16/21 | 4/14/22 | 4/14/23 | 4/11/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 28.34 | 32.38 | 63.1 | 85.92 | 60.9 | 53.41 |
EBITDA 1 | 4.017 | 5.186 | 14.32 | 17.81 | 10.4 | 7.332 |
EBIT 1 | 3.266 | 4.261 | 13.27 | 16.4 | 8.761 | 3.389 |
Operating Margin | 11.52% | 13.16% | 21.03% | 19.08% | 14.39% | 6.34% |
Earnings before Tax (EBT) 1 | 3.378 | 4.617 | 13.87 | 17.29 | 9.324 | 4.383 |
Net income 1 | 2.275 | 3.14 | 9.202 | 11.4 | 6.29 | 2.271 |
Net margin | 8.03% | 9.7% | 14.58% | 13.27% | 10.33% | 4.25% |
EPS 2 | 0.4500 | 0.6292 | 1.820 | 2.250 | 1.240 | 0.4483 |
Free Cash Flow 1 | 1.235 | 0.3986 | 7.673 | 6.072 | -1.852 | 6.465 |
FCF margin | 4.36% | 1.23% | 12.16% | 7.07% | -3.04% | 12.1% |
FCF Conversion (EBITDA) | 30.75% | 7.69% | 53.58% | 34.09% | - | 88.18% |
FCF Conversion (Net income) | 54.31% | 12.69% | 83.38% | 53.25% | - | 284.64% |
Dividend per Share 2 | 0.4000 | 0.1000 | 1.000 | 1.000 | 0.7500 | 0.5000 |
Announcement Date | 4/9/19 | 4/21/20 | 4/16/21 | 4/14/22 | 4/14/23 | 4/11/24 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - | - |
Net Cash position 1 | 10.4 | 8.45 | 19.2 | 20.7 | 14.7 | 16.6 |
Leverage (Debt/EBITDA) | - | - | - | - | - | - |
Free Cash Flow 1 | 1.24 | 0.4 | 7.67 | 6.07 | -1.85 | 6.47 |
ROE (net income / shareholders' equity) | 10.7% | 14.4% | 36% | 34% | 16.2% | 5.5% |
ROA (Net income/ Total Assets) | 7.44% | 8.95% | 21.6% | 20.1% | 9.37% | 3.64% |
Assets 1 | 30.57 | 35.09 | 42.54 | 56.64 | 67.12 | 62.34 |
Book Value Per Share 2 | 4.170 | 4.410 | 6.150 | 7.410 | 7.660 | 7.360 |
Cash Flow per Share 2 | 1.890 | 1.600 | 3.480 | 3.610 | 2.660 | 2.830 |
Capex 1 | 2.12 | 0.91 | 3.29 | 3.88 | 6.37 | 1.84 |
Capex / Sales | 7.49% | 2.8% | 5.21% | 4.52% | 10.45% | 3.45% |
Announcement Date | 4/9/19 | 4/21/20 | 4/16/21 | 4/14/22 | 4/14/23 | 4/11/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-1.64% | 48.75M | |
-14.92% | 84.68B | |
+13.30% | 81.12B | |
+10.92% | 29.4B | |
-12.71% | 16.73B | |
-3.06% | 16.36B | |
-2.63% | 14.92B | |
-31.75% | 11.77B | |
-1.42% | 11.72B | |
+27.44% | 11.71B |
- Stock Market
- Equities
- AJ91 Stock
- Financials DocCheck AG